Type 2 Innovation Grant 2020
IMPORTANT – Deadline for application submission has been extended from May 31st to June 15th 11:59 pm CEST
SUBMIT YOUR APPLICATION NOW
Independent research is crucial in discovering new ways to improve human health. That’s why, at Sanofi Genzyme, we are taking an active role in helping research initiatives become a reality by offering research grants to ten innovative projects designed to improve the lives of people with immune-mediated diseases (the “Type 2 Innovation Grant”).
We have involved IntraMed Communications S.r.l., located at Via Raffaello Bertieri 4, 20146 Milan, Italy (“IntraMed”) to operate and manage the Type 2 Innovation Grant on our behalf.
If you are interested in participating in the 2020 edition of the Type 2 Innovation Grant, check “The research grant” tab for more information.